Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.

Publication ,  Journal Article
Vickery, BP; Scurlock, AM; Kulis, M; Steele, PH; Kamilaris, J; Berglund, JP; Burk, C; Hiegel, A; Carlisle, S; Christie, L; Perry, TT ...
Published in: J Allergy Clin Immunol
February 2014

BACKGROUND: Although peanut oral immunotherapy (OIT) has been conclusively shown to cause desensitization, it is currently unknown whether clinical protection persists after stopping therapy. OBJECTIVE: Our primary objective was to determine whether peanut OIT can induce sustained unresponsiveness after withdrawal of OIT. METHODS: We conducted a pilot clinical trial of peanut OIT at 2 US centers. Subjects age 1 to 16 years were recruited and treated for up to 5 years with peanut OIT. The protocol was modified over time to permit dose increases to a maximum of 4000 mg/d peanut protein. Blood was collected at multiple time points. Clinical end points were measured with 5000-mg double-blinded, placebo-controlled food challenges once specific criteria were met. RESULTS: Of the 39 subjects originally enrolled, 24 completed the protocol and had evaluable outcomes. Twelve (50%) of 24 successfully passed a challenge 1 month after stopping OIT and achieved sustained unresponsiveness. Peanut was added to the diet. At baseline and the time of challenge, such subjects had smaller skin test results, as well as lower IgE levels specific for peanut, Ara h 1, and Ara h 2 and lower ratios of peanut-specific IgE/total IgE compared with subjects not passing. There were no differences in peanut IgG₄ levels or functional activity at the end of the study. CONCLUSIONS: This is the first demonstration of sustained unresponsiveness after peanut OIT, occurring in half of subjects treated for up to 5 years. OIT favorably modified the peanut-specific immune response in all subjects completing the protocol. Smaller skin test results and lower allergen-specific IgE levels were predictive of successful outcome.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

February 2014

Volume

133

Issue

2

Start / End Page

468 / 475

Location

United States

Related Subject Headings

  • Skin Tests
  • Plant Proteins
  • Peanut Hypersensitivity
  • Membrane Proteins
  • Infant
  • Immunoglobulin E
  • Humans
  • Glycoproteins
  • Double-Blind Method
  • Desensitization, Immunologic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vickery, B. P., Scurlock, A. M., Kulis, M., Steele, P. H., Kamilaris, J., Berglund, J. P., … Burks, A. W. (2014). Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol, 133(2), 468–475. https://doi.org/10.1016/j.jaci.2013.11.007
Vickery, Brian P., Amy M. Scurlock, Michael Kulis, Pamela H. Steele, Janet Kamilaris, Jelena P. Berglund, Caitlin Burk, et al. “Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.J Allergy Clin Immunol 133, no. 2 (February 2014): 468–75. https://doi.org/10.1016/j.jaci.2013.11.007.
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014 Feb;133(2):468–75.
Vickery, Brian P., et al. “Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.J Allergy Clin Immunol, vol. 133, no. 2, Feb. 2014, pp. 468–75. Pubmed, doi:10.1016/j.jaci.2013.11.007.
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014 Feb;133(2):468–475.
Journal cover image

Published In

J Allergy Clin Immunol

DOI

EISSN

1097-6825

Publication Date

February 2014

Volume

133

Issue

2

Start / End Page

468 / 475

Location

United States

Related Subject Headings

  • Skin Tests
  • Plant Proteins
  • Peanut Hypersensitivity
  • Membrane Proteins
  • Infant
  • Immunoglobulin E
  • Humans
  • Glycoproteins
  • Double-Blind Method
  • Desensitization, Immunologic